France· FR:61662851
PURIVIST 0,5 mg/ml, collyre en solution
A medicinal product containing chlorhydrate d'épinastine, registered in France by ABBVIE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE D'ÉPINASTINE
- Manufacturer
- ABBVIE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009362265311 flacon(s) polyéthylène de 5 mlEUR 5.35
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate d'épinastine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRelestat 0.5 mg/mlAbbvie
- CzechiaPURIVISTAbbVie s.r.o., Praha
- FinlandRelestatAllergan Pharmaceuticals Ireland
- IrelandRelestat, 0.5 mg/ml, eye drops, solutionAbbVie Limited
- NetherlandsRelestat, oogdruppels, oplossing 0,5 mg/mlAbbVie B.V.
- PolandRelestatAbbVie Sp. z o.o.
- SwedenRelestat 0,5 mg/ml Ögondroppar, lösningAbbVie AB
- United StatesEPINASTINE HYDROCHLORIDESomerset Therapeutics, LLC
Authorised across Europe · EMA
The same active substance is authorised in 12 EEA countries. Names it is sold under:
- Belgium · Relestat
- Czechia · Purivist
- United Kingdom (Northern Ireland) · Relestat
- Greece · Optallerg, Relestat
- Hungary · Relestat
- Ireland · Relestat
- Italy · Relestat
- Luxembourg · Relestat
- Netherlands · Relestat
- Portugal · Relestat
- Sweden · Relestat
- Slovakia · Purivist
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6893eed4-6322-4a7d-9003-abad3a44149e GET /v1/drugs/6893eed4-6322-4a7d-9003-abad3a44149e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61662851",
"date_amm": "2003-07-16",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "CHLORHYDRATE D'ÉPINASTINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate d'épinastine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.